A 5-year neutralizing immune response to yellow fever vaccine in HIV-infected and HIV-uninfected adults
暂无分享,去创建一个
A. Samri | B. Autran | O. Launay | C. Durier | S. Matheron | F. Simon | V. Meiffrédy | S. Mercier-Delarue | L. Marchand | Martin Resch | Nathalie Colin De Verdière
[1] S. De Wit,et al. Immunogenicity and duration of protection after yellow fever vaccine in people living with HIV: A systematic review. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[2] A. Samri,et al. Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients , 2018, AIDS.
[3] A. Trkola,et al. Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)–Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination Schedule , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Césaire,et al. Screening test for neutralizing antibodies against yellow fever virus, based on a flavivirus pseudotype , 2017, PloS one.
[5] P. Böelle,et al. Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] K. Lacombe,et al. Plasma HIV-RNA Is the Key Determinant of Long-Term Antibody Persistence After Yellow Fever Immunization in a Cohort of 364 HIV-Infected Patients , 2012, Journal of acquired immune deficiency syndromes.
[7] R. van Furth,et al. Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] J. D. de Jong,et al. Antibody response to influenza, tetanus and pneumococcal vaccines in HIV‐seropositive individuals in relation to the number of CD4+ lymphocytes , 1994, AIDS.
[9] O. Kosoy,et al. Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers. , 2018, Journal of travel medicine.
[10] Vaccines and vaccination against yellow fever: WHO Position Paper, June 2013--recommendations. , 2015, Vaccine.